On this page
SCARB2
scavenger receptor class B member 2
The SCARB2 gene provides instructions for producing the LIMP-2 protein, which is critical for lysosomal function, particularly in transporting an enzyme involved in breaking down fatty substances. SCARB2 encodes the lysosomal integral membrane protein-2 (LIMP-2), a protein primarily located in lysosomes where it helps maintain stability and transports essential enzymes.
SCARB2 is located on the long (q) arm of chromosome 4, at band 4q21.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 4 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The SCARB2 gene, also known as scavenger receptor class B member 2, is responsible for creating the lysosomal integral membrane protein-2 (LIMP-2). This protein plays a crucial role within lysosomes, cellular compartments that digest and recycle various materials within the cell. Beyond its lysosomal functions, LIMP-2 is also observed in other cellular locations and has diverse roles, including interactions with certain viruses.
What the gene does
The LIMP-2 protein, encoded by SCARB2, is primarily found within the membrane of lysosomes, where it contributes to their stability. A key function of LIMP-2 is to transport the enzyme beta-glucocerebrosidase from the endoplasmic reticulum to the lysosome. Once in the lysosome, beta-glucocerebrosidase is essential for breaking down glucocerebroside, a fatty substance. The LIMP-2 protein can also be found in the outer cell membrane, where certain viruses, including enterovirus 71 and specific coxsackievirus strains, can attach to it to gain entry into cells. In the heart, LIMP-2 is present in intercalated discs, and research suggests it may have a role in cases of abnormal heart muscle enlargement, though its precise mechanism remains unclear.
Video: Genetics 101
Chromosome location
The SCARB2 gene is located on the long arm of chromosome 4, specifically at position 4q21.1. This genomic location positions the gene within a region that contributes to its expression and function within the cellular machinery.
Protein structure
The LIMP-2 protein consists of 478 amino acids. A specific region spanning amino acids 155-191 is identified as important for its interaction with the GBA1 protein. This interaction is crucial for the proper transport of beta-glucocerebrosidase to the lysosome.
Key variants
Genetic variations within the SCARB2 gene can lead to alterations in the structure or function of the LIMP-2 protein. These changes may impair its ability to perform its normal roles, such as transporting enzymes to lysosomes or maintaining lysosomal stability. Such variants can disrupt cellular processes and contribute to the development of associated inherited conditions.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1002dup | p.Ile335fs | Pathogenic/Likely pathogenic | ★★☆☆ | Action myoclonus-renal failure syndrome |
c.1270C>T | p.Arg424Ter | Pathogenic | ★★☆☆ | Action myoclonus-renal failure syndrome |
c.235del | p.Glu79fs | Pathogenic/Likely pathogenic | ★★☆☆ | Progressive myoclonic epilepsy |
c.361C>T | p.Arg121Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Progressive myoclonic epilepsy |
c.434_435dup | p.Trp146fs | Pathogenic | ★★☆☆ | SCARB2-related disorder |
c.704+1G>A | - | Pathogenic | ★★☆☆ | Action myoclonus-renal failure syndrome |
c.862C>T | p.Gln288Ter | Pathogenic | ★★☆☆ | Progressive myoclonic epilepsy |
c.88C>T | p.Gln30Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Progressive myoclonic epilepsy |
c.956del | p.Leu319fs | Pathogenic | ★★☆☆ | Progressive myoclonic epilepsy |
c.994+1G>T | - | Pathogenic | ★☆☆☆ | Action myoclonus-renal failure syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the SCARB2 gene are associated with inherited conditions, most notably Action myoclonus-renal failure (AMRF). This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the altered gene (one from each parent) to be affected. AMRF is characterised by involuntary muscle jerking and progressive kidney disease.
Inheritance pattern
Conditions caused by pathogenic SCARB2 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
SCARB2 is assessed for its relevance to several conditions within the NHS Genomic Medicine Service. It is currently included on gene panels for Early onset or syndromic epilepsy, Hereditary neuropathy or pain disorder, Proteinuric renal disease, and Unexplained kidney failure in young people, indicating its clinical significance in these areas within the UK.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the SCARB2 gene?
The SCARB2 gene provides instructions for making the LIMP-2 protein, which is primarily involved in lysosomal function. It helps transport the enzyme beta-glucocerebrosidase to lysosomes and plays a role in maintaining lysosomal stability.
How is Action myoclonus-renal failure (AMRF) related to SCARB2?
Action myoclonus-renal failure (AMRF) is an inherited condition caused by pathogenic variants in the SCARB2 gene. Individuals with AMRF typically experience involuntary muscle jerking and progressive kidney disease.
Can SCARB2 affect other body systems besides lysosomes?
Yes, beyond its primary role in lysosomes, the LIMP-2 protein encoded by SCARB2 is also found in the heart, specifically in intercalated discs, and may be involved in responses to abnormal heart muscle enlargement. It can also serve as a receptor for certain viruses on the outer cell membrane.
References
- Gonzalez A, Valeiras M, Sidransky E. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology. Molecular genetics and metabolism. 2014. PMID: 24389070
- Dang M, Wang X, Wang Q. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein & cell. 2014. PMID: 24986489
- Dibbens LM, Michelucci R, Gambardella A. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Annals of neurology. 2009. PMID: 19847901
- Berkovic SF, Dibbens LM, Oshlack A. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. American journal of human genetics. 2008. PMID: 18308289
- Balreira A, Gaspar P, Caiola D. A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome. Human molecular genetics. 2008. PMID: 18424452
- Schroen B, Leenders JJ, van Erk A. Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy. The Journal of experimental medicine. 2007. PMID: 17485520